Acute Biphenotypic Leukemia (ABL) Active Not Recruiting Phase 2 Trials for Treosulfan (DB11678)

Also known as: Acute biphenotypic leukaemia / Acute Biphenotypic Leukemia / Leukemia, Biphenotypic, Acute / Acute bilineal leukemia

IndicationStatusPhase
DBCOND0081399 (Acute Biphenotypic Leukemia (ABL))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00796068Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood TransplantTreatment